MSI1 and cancer: In contrast to Vo et al.’s observation of a survival disadvantage associated with higher levels of MSI1 protein on MB patient specimens37, we did not find as strong an association between MSI1 transcript levels and patient survival, highlighting concerns of exclusively transcriptomic-based interpretations of cancer biology and subsequent targeted drug selection (Supplementary Fig. 1a).